Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Witzens-Harig
Mathias
M
Waldherr
Rüdiger
R
Beimler
Joerg
J
Zeier
Martin
M
Hansmann
Jochen
J
Ho
Anthony D
AD
Goldschmidt
Hartmut
H
Moehler
Thomas
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005920:Glomerular Mesangium / Q000737:chemistry / Q000473:pathology; D005921:Glomerulonephritis / Q000209:etiology*; D006801:Humans; D007145:Immunoglobulin kappa-Chains / Q000032:analysis; D008279:Magnetic Resonance Imaging; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D009194:Myeloma Proteins / Q000032:analysis; D036102:Peripheral Blood Stem Cell Transplantation; D011507:Proteinuria / Q000209:etiology*; D012074:Remission Induction; D014182:Transplantation, Autologous; D014750:Vincristine / Q000008:administration & dosage
D007145:Immunoglobulin kappa-Chains; D009194:Myeloma Proteins; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan